Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization NodThera Ltd.Startup |
Active Organization NodThera Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroinflammation | IND Application | GB | NodThera Ltd.Startup | 11 May 2022 |